Dashboard
Manage Tickers

PTNPALATIN TECHNOLOGIES INC

NYSE palatin.com


$ 1.90 $ 0.02 (1.08 %)    

Tuesday, 02-Jul-2024 15:57:16 EDT
CLICK TO SEE RELEVANT LITIGATION UPDATES
Y-mAbs Therapeutics, Inc. | YMAB | Take Action!
QQQ $ 486.52 $ 6.63 (1.38 %)
DIA $ 393.25 $ 1.83 (0.47 %)
SPY $ 548.30 $ 2.96 (0.54 %)
TLT $ 90.61 $ 0.70 (0.78 %)
GLD $ 215.57 $ -0.01 (0 %)
$ 1.88
$ 1.87
$ 0.00 x 0
$ 0.00 x 0
$ 1.80 - $ 1.90
$ 1.43 - $ 5.65
70,895
na
30.34M
$ 1.06
nm
TBD
na
na ($ 0.00)
na
TBD na
How to Read 10-K & 10-Q Reports To View SEC Filing Reports, Please Register or Sign In
# Filing Date Period End Date Type Report Link
1 05-15-2024 03-31-2024 10-Q
2 02-14-2024 12-31-2023 10-Q
3 11-14-2023 09-30-2023 10-Q
4 09-28-2023 06-30-2023 10-K
5 05-15-2023 03-31-2023 10-Q
6 02-14-2023 12-31-2022 10-Q
7 11-14-2022 09-30-2022 10-Q
8 09-22-2022 06-30-2022 10-K
9 05-16-2022 03-31-2022 10-Q
10 02-14-2022 12-31-2021 10-Q
11 11-15-2021 09-30-2021 10-Q
12 09-28-2021 06-30-2021 10-K
13 05-14-2021 03-31-2021 10-Q
14 02-16-2021 12-31-2020 10-Q
15 11-16-2020 09-30-2020 10-Q
16 09-25-2020 06-30-2020 10-K
17 05-11-2020 03-31-2020 10-Q
18 02-10-2020 12-31-2019 10-Q
19 11-12-2019 09-30-2019 10-Q
20 09-12-2019 06-30-2019 10-K
21 05-09-2019 03-31-2019 10-Q
22 02-11-2019 12-31-2018 10-Q
23 11-09-2018 09-30-2018 10-Q
24 09-13-2018 06-30-2018 10-K
25 05-14-2018 03-31-2018 10-Q
26 02-12-2018 12-31-2017 10-Q
27 11-13-2017 09-30-2017 10-Q
28 09-25-2017 06-30-2017 10-K
29 05-15-2017 03-31-2017 10-Q
30 02-10-2017 12-31-2016 10-Q
31 11-14-2016 09-30-2016 10-Q
32 09-19-2016 06-30-2016 10-K
33 05-16-2016 03-31-2016 10-Q
34 02-12-2016 12-31-2015 10-Q
35 11-12-2015 09-30-2015 10-Q
36 09-18-2015 06-30-2015 10-K
37 05-12-2015 03-31-2015 10-Q
38 02-12-2015 12-31-2014 10-Q
39 11-14-2014 09-30-2014 10-Q
40 09-12-2014 06-30-2014 10-K
Guide for Analyst Ratings To View Analyst Ratings, Please Register or Sign In
# Date Analyst Firm Upside/Downside Price Target Change Rating Change Current Rating

News

OPINIONS

palatin-technologies-enters-warrant-inducement-agreement-with-institutional-investor-to-exercise-3233277-shares-issued-in-november-2022-and-october-2023-raising-61m
Palatin Technologies Enters Warrant Induce...
06/21/2024 12:04:07

hc-wainwright--co-reiterates-buy-on-palatin-techs-maintains-17-price-target
HC Wainwright & Co. Reiterates Buy on Pala...
06/20/2024 15:28:37

HC Wainwright & Co. analyst Joseph Pantginis reiterates Palatin Techs (AMEX:PTN) with a Buy and maintains $17 price target.

palatin-technologies-has-initiated-phase-2-study-of-bremelanotide-a-melanocortin-4-receptor-co-administered-with-a-phosphodiesterase-5-inhibitor-for-erectile-dysfunction-in-patients-that-do-not-respond-to-pde5i-monotherapy-topline-data-is-expected-by
Palatin Technologies Has Initiated Phase 2...
06/20/2024 11:59:13

hc-wainwright--co-reiterates-buy-on-palatin-techs-maintains-17-price-target
HC Wainwright & Co. Reiterates Buy on Pala...
06/12/2024 12:26:27

HC Wainwright & Co. analyst Joseph Pantginis reiterates Palatin Techs (AMEX:PTN) with a Buy and maintains $17 price target.

palatin-begins-phase-2-trial-to-assess-combined-efficacy-of-bremelanotide-and-tirzepatide-in-obesity-management
Palatin Begins Phase 2 Trial To Assess Com...
06/12/2024 11:34:08

Co-Administration Phase 2 study of bremelanotide with tirzepatide (GLP-1) to provide key information for melanocortin treatme...

hc-wainwright--co-reiterates-buy-on-palatin-techs-maintains-17-price-target
HC Wainwright & Co. Reiterates Buy on Pala...
05/15/2024 18:02:19

HC Wainwright & Co. analyst Joseph Pantginis reiterates Palatin Techs (AMEX:PTN) with a Buy and maintains $17 price target.

as-of-march-31-2024-palatins-cash-cash-equivalents-and-marketable-securities-were-10m-expected-to-provide-cash-runway-into-second-half-of-calendar-year-2024
As Of March 31, 2024, Palatin's Cash, Cash...
05/15/2024 11:39:12

palatin-techs-q3-2024-gaap-eps-053-misses-050-estimate
Palatin Techs Q3 2024 GAAP EPS $(0.53) Mis...
05/15/2024 11:32:54

hc-wainwright--co-reiterates-buy-on-palatin-techs-maintains-17-price-target
HC Wainwright & Co. Reiterates Buy on Pala...
05/08/2024 19:27:58

HC Wainwright & Co. analyst Joseph Pantginis reiterates Palatin Techs (AMEX:PTN) with a Buy and maintains $17 price target.

hc-wainwright--co-reiterates-buy-on-palatin-techs-maintains-17-price-target
HC Wainwright & Co. Reiterates Buy on Pala...
05/02/2024 17:24:43

HC Wainwright & Co. analyst Joseph Pantginis reiterates Palatin Techs (AMEX:PTN) with a Buy and maintains $17 price target.

fda-clears-palatins-ind-application-for-phase-2-study-of-bremelanotide-co-administered-with-tirzepatide-for-obesity-the-phase-2-study-is-expected-to-start-by-mid-2024-with-topline-data-results-by-the-end-of-2024
FDA Clears Palatin's IND Application For P...
05/02/2024 11:38:08

palatin-technologies-and-2-other-stocks-under-3-insiders-are-buying
Palatin Technologies And 2 Other Stocks Un...
04/12/2024 12:36:12

The Dow Jones index closed slightly lower on Thursday. When insiders purchase or sell shares, it indicates their confidence or ...

palatin-technologies-eyes-growing-6b-dry-eye-disease-market-with-late-stage-study-data
Palatin Technologies Eyes Growing $6B Dry ...
04/08/2024 14:02:37

Palatin Technologies unveils Phase 3 PL9643 MELODY-1 trial results for dry eye disease treatment, showcasing statistically sign...

palatin-announces-phase-3-pl9643-melody-1-dry-eye-disease-ded-clinical-data-results-presented-at-american-society-of-cataract-and-refractive-surgery-ascrs-2024
Palatin Announces Phase 3 PL9643 MELODY-1 ...
04/08/2024 11:31:41

Palatin Technologies, Inc. (NYSE:PTN), a biopharmaceutical company developing first-in-class medicines based on molecules that ...

why-bumble-shares-are-trading-lower-by-12-here-are-other-stocks-moving-in-wednesdays-mid-day-session
Why Bumble Shares Are Trading Lower By 12%...
02/28/2024 19:02:02

Shares of Bumble Inc. (NASDAQ: BMBL) fell sharply during Wednesday’s session following weak quarterly results.

hc-wainwright--co-maintains-buy-on-palatin-techs-adjusts-price-target-to-17
HC Wainwright & Co. Maintains Buy on Palat...
02/28/2024 18:16:20

HC Wainwright & Co. analyst Joseph Pantginis maintains Palatin Techs (AMEX:PTN) with a Buy, adjusts target to $17 from $70.

12-health-care-stocks-moving-in-wednesdays-intraday-session
12 Health Care Stocks Moving In Wednesday'...
02/28/2024 17:31:10

palatin-technologies-disappointing-data-from-dry-eye-disease-study-stock-plummets
Palatin Technologies' Disappointing Data F...
02/28/2024 15:57:53

Palatin Technologies' results from PL9643 MELODY-1 Phase 3 trial for dry eye disease. The co-primary endpoints and secondar...

dow-dips-200-points-tjx-posts-upbeat-sales
Dow Dips 200 Points; TJX Posts Upbeat Sales
02/28/2024 15:12:21

U.S. stocks traded lower this morning, with the Dow Jones index falling around 200 points on Wednesday. Following the market o...

palatin-technologies-shared-resumed-trade
Palatin Technologies Shared Resumed Trade
02/28/2024 14:44:31

CORE & Plaid

CORE & Plaid

CORE Finalist

CLASS ACTION DEADLINES - JOIN NOW!

07/02/2024 Intel Corporation (INTC)
07/05/2024 AXT, Inc. (AXTI)
07/05/2024 Altimmune, Inc. (ALT)
07/09/2024 Li Auto Inc. (LI)
07/12/2024 Inari Medical, Inc. (NARI)
07/12/2024 Sprout Social, Inc. (SPT)
07/15/2024 UnitedHealth Group Inc. (UNH)
07/16/2024 Teladoc Health, Inc. (TDOC)
07/16/2024 Vestis Corporation (VSTS)
07/22/2024 Cambium Networks Corporation (CMBM)

NEW CASE INVESTIGATION

Ooma Inc (OOMA) AnaptysBio Inc (ANAB)